Status:
COMPLETED
New Approach of Loco Regional Analgesia in Kidney Transplant
Lead Sponsor:
CHU de Reims
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Kidney transplant is considered as a moderate painful surgery. Unfortunately, patients with chronic kidney disease are not able to degrade opioid drugs and are therefore most likely to be subjected to...
Detailed Description
Post-operative pain after a kidney transplant can be moderate to severe, but analgesic options are limited. Clearance of the active metabolite of morphin is low in patients with chronic kidney disease...
Eligibility Criteria
Inclusion
- Patients eligible for kidney transplant surgery at the CHU de Reims
- Patients agreeing to participate in the research and having signed the informed consent
- Adult patients
- Patients affiliated to a social security scheme
Exclusion
- Legally protected
- Known allergy to local anesthetics used
- Manifest polyneuropathy
- ASA score \> 4
- Pregnancy, breastfeeding
- Contraindications to QLB
- Technique refusal
- Previous kidney transplant
- History of major abdominal surgery
Key Trial Info
Start Date :
August 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 23 2022
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05391451
Start Date
August 31 2021
End Date
October 23 2022
Last Update
November 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France